NANoor AlAnazi

Noor AlAnazi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Noor AlAnazi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Ahmed Al Sarkhy

    Department of Pediatrics, Gastroenterology Division, King Saud University, Riyadh, Kingdom of Saudi Arabia

    1 shared publication
  • Ali Al Hassan

    Department of Pediatrics, Gastroenterology Unit, College of Medicine, King Saud University, Riyadh; Department of Pediatrics, Maternity and Childhood Hospital, Ahsa, Saudi Arabia

    1 shared publication
  • Asaad Assiri

    Gastroenterology Division, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia

    1 shared publication
  • Hayfa Alabdulkarim

    Gastroenterology Division, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia

    1 shared publication
  • Heba Assiri

    Department of Pediatrics, Gastroenterology Unit, College of Medicine, King Saud University, Riyadh, Saudi Arabia

    1 shared publication
  • Mohammad El Mouzan

    Department of Pediatrics, Gastroenterology Unit, College of Medicine, King Saud University; Department of Pediatrics, Prince Abdullah Bin Khalid Celiac Disease Research Chair, King Saud University, Riyadh, Saudi Arabia

    1 shared publication

Latest Publications

  • Open Access

    Frequency and Predictive Factors for Spontaneous Normalization of Anti-Tissue Transglutaminase-IgA Serology among Saudi Children with Type 1 Diabetes Mellitus: A Cohort Study

    by Ahmed Al Sarkhy, Ali Al Hassan, Heba Assiri, Hayfa Alabdulkarim, Noor AlAnazi, Nawaf Alshammari, Najla AlOtaibi, Mona Al Asmi, Asaad Assiri, Reem Al-Khalifah, et al.

    Bodies in these patients. Methods: The charts of all patients (≤18 years) with T1DM were retrospectively reviewed from 2012 to 2021 at a tertiary care center in Riyadh, Saudi Arabia. The following data were collected: clinical characteristics of the participants, anti-TTG-IgA-immunoglobulin (Ig) A antibody, and histological findings. The outcome of positive anti-TTG-IgA-IgA in patients with T1DM and the predictive factors for spontaneous normalization were investigated. Results: Of the 1,006 patients with T1DM, 138 (13.7%) had elevated anti-TTG-IgA antibodies, celiac disease was diagnosed in 58/138 (42%) patients, spontaneous normalization of anti-TTG-IgA was observed in 65 (47.1%) patients, and fluctuating anti-TTG-IgA antibodies were seen in 15 (10.9%) patients. The patients with anti-TTG-IgA levels at 3–10 times the upper normal limits (UNL), and those with levels ≥10 times UNL were less likely to have spontaneous normalization of anti-TTG-IgA compared to patients with levels at 1–3 times UNL (hazard ratio [HR] = 0.28, 95% confidence interval [Cl] = 0.13–0.61, P = 0.001, and HR = 0.03, 95% Cl = 0.00–0.19, P < 0.001, respectively). Conclusion: Asymptomatic patients with T1DM with mild elevation of anti-TTG-IgA need not be rushed for invasive endoscopy or exposed to an un-needed gluten-free diet but should rather have a regular follow-up of their celiac serology....